Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fidelma P Dunne

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Diabetes Research and Clinical Practice|July 30, 2022
The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
BMJ Open|November 16, 2019
Gestational diabetes prevention and treatment: a protocol for developing core outcome setsAoife Maria Egan, Fidelma P Dunne, Linda M Biesty, et al.
Diabetes Care|November 21, 2020
Core Outcome Sets for Studies of Diabetes in Pregnancy: A ReviewAoife M Egan, Delia Bogdanet, Linda Biesty, et al.
BMC Pregnancy and Childbirth|October 27, 2015
Health related quality of life two to five years after gestational diabetes mellitus: cross-sectional comparative study in the ATLANTIC DIP cohortAndriy Danyliv, Paddy Gillespie, Ciaran O'Neill, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 20, 2023
The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screeningDelia Bogdanet, Michelle T Castillo, Helen Doheny, et al.
Journal of Clinical Medicine|July 9, 2022
The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
Acta Diabetologica|October 30, 2022
The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
Trials|June 21, 2013
An evaluation of Croí MyAction community lifestyle modification programme compared to standard care to reduce progression to diabetes/pre-diabetes in women with prior gestational diabetes mellitus (GDM): study protocol for a randomised controlled trialJennifer J Infanti, Fidelma P Dunne, Angela O'Dea, et al.
Trials|January 21, 2014
Screening uptake rates and the clinical and cost effectiveness of screening for gestational diabetes mellitus in primary versus secondary care: study protocol for a randomised controlled trialAngela O'Dea, Jennifer J Infanti, Paddy Gillespie, et al.
Acta Diabetologica|July 9, 2014
ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteriaEoin Noctor, Catherine Crowe, Louise A Carmody, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Diabetes Research and Clinical Practice|July 30, 2022
The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
BMJ Open|November 16, 2019
Gestational diabetes prevention and treatment: a protocol for developing core outcome setsAoife Maria Egan, Fidelma P Dunne, Linda M Biesty, et al.
Diabetes Care|November 21, 2020
Core Outcome Sets for Studies of Diabetes in Pregnancy: A ReviewAoife M Egan, Delia Bogdanet, Linda Biesty, et al.
BMC Pregnancy and Childbirth|October 27, 2015
Health related quality of life two to five years after gestational diabetes mellitus: cross-sectional comparative study in the ATLANTIC DIP cohortAndriy Danyliv, Paddy Gillespie, Ciaran O'Neill, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 20, 2023
The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screeningDelia Bogdanet, Michelle T Castillo, Helen Doheny, et al.
Journal of Clinical Medicine|July 9, 2022
The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
Acta Diabetologica|October 30, 2022
The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
Trials|June 21, 2013
An evaluation of Croí MyAction community lifestyle modification programme compared to standard care to reduce progression to diabetes/pre-diabetes in women with prior gestational diabetes mellitus (GDM): study protocol for a randomised controlled trialJennifer J Infanti, Fidelma P Dunne, Angela O'Dea, et al.
Trials|January 21, 2014
Screening uptake rates and the clinical and cost effectiveness of screening for gestational diabetes mellitus in primary versus secondary care: study protocol for a randomised controlled trialAngela O'Dea, Jennifer J Infanti, Paddy Gillespie, et al.
Acta Diabetologica|July 9, 2014
ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteriaEoin Noctor, Catherine Crowe, Louise A Carmody, et al.
Pageof 6